米国市場銘柄情報

GEF グライフ A

銘柄追加

63.460
+0.180+0.28%

終値 05/07 16:00 ET

36.67億時価総額10.98直近PER

グライフ Aに関するコメント

ログインコメントを投稿

Moomoo AI

03/27 04:10

Greif's CEO, Ole Rosgaard, sees the acquisition as a crucial step in their Build to Last strategy, unlocking new capabilities and market opportunities. The company aims to drive benefits, support growth, and capture $7 million of synergies through Ipackchem's integration.

Press Release: Greif Completes Acquisition of Ipackchem

Moomoo AI

03/04 20:56

Insider selling of shares, particularly below current price, is seen as negative, implying a lower price is reasonable. High insider ownership in Greif may suggest management's consideration for shareholder interests. The absence of insider transactions in the past three months is not confidence-inspiring.

Possible Bearish Signals With Greif Insiders Disposing Stock

Stock_Drift

02/08 12:28

🚨 GAINERS 2/7/2024 🚨
$シーラスロジック(CRUS.US)$ $グリーンプレーンズ(GPRE.US)$ $Hitek Global(HKIT.US)$ $グライフ A(GEF.US)$
📊⚡️📊

Moomoo AI

01/23 19:52

The low P/E ratio of Greif, Inc. might be due to expected EPS slump. Investors may not see earnings improvement potential to justify a higher P/E ratio, possibly limiting future share price growth.

Little Excitement Around Greif, Inc.'s (NYSE:GEF) Earnings

Moomoo AI

01/02 21:31

High debt carried by the company raises concerns given the substantial reliance on borrowed funds. When considering ROE, other indicators such as profit growth rates and stock pricing must also be evaluated.

Is Greif, Inc.'s (NYSE:GEF) ROE Of 18% Impressive?

Moomoo AI

2023/10/25 21:31

Insider transactions indicate mixed sentiment: high level of insider ownership may imply alignment with shareholder interests. However, the share sales, particularly below current prices, may signal lack of confidence in future prospects.

Greif Insiders Sold US$1.9m Of Shares Suggesting Hesitancy

Moomoo Breakfast US

2022/06/09 20:23

コラムToday's pre-market stock movers: NIO, NVAX, TSLA, SIG and more

Gainers:
• $シグネットジュエラーズ(SIG.US)$ +7.6% (In reaction to earnings/guidance)
• $オックスフォードインダストリーズ(OXM.US)$ +6.3% (In reaction to earnings/guidance)
• $ブリッジバイオファーマ(BBIO.US)$ +5%(to Present Phase 2b Data and Pivotal Phase 3 Study Design of Encaleret in Autosomal Dominant Hypocalcemia Type 1 (ADH1) at the Endocrine Society (ENDO) 2022 Annual Conference)
• $グライフ A(GEF.US)$ +4.6% (In reaction to earnings/guidance)
• $オレマファーマシューティクス(OLMA.US)$ +4.3% (an...